Analytical Chemists in Demand

Analytical chemists trekking to New Orleans for this month’s Pittsburgh conference might be forgiven a certain amount of hubris. Their services are in demand, by industry and academia, as never before. “I think it’s the tightest area in chemistry, with the possible exception of polymer chemistry,” declares Ted Logan, Manager of Ph.D. recruiting at Procter & Gamble Co. Actually, the U.S. supply of Ph.D.s in analytical chemistry is rising. The compound growth rate of 6.7

Written byPeter Gwynne
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Actually, the U.S. supply of Ph.D.s in analytical chemistry is rising. The compound growth rate of 6.7 percent between 1981 and 1985 was almost double the 3.7 percent that applied to all chemistry Ph.D.s. But that level of growth is still too slow to meet the rapidly rising industrial demand. In fact industry recruiters worry that their offers of high salaries and state-of-the-art equipment will draw too many analytical chemists away from academia, and hence threaten the supply of the next generation of Ph.D.s.

What has created the demand? Experts point to a combination of advances in basic chemistry, new technology, and the broadening nature of present-day research.

With the emergence of large molecule chemistry and biotechnology, explains Henry Blount, program director for analytical and surface chemistry at the National Science Foundation, analytical chemists have to make their measurements in entirely new and tough environments—in fermentation vats, and at extremes ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies